Skip to the page

Data / Form D filings / JUVENTAS THERAPEUTICS INC

JUVENTAS THERAPEUTICS INC: Form D filings

JUVENTAS THERAPEUTICS INC, a biotechnology company in Cleveland, OH, filed 5 Form D notices with the SEC between 2012 and 2017. The latest, on October 4, 2017, reports $1.3 million sold of a $6 million offering to 46 investors.

Find out what JUVENTAS THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3615 Superior Avenue, Suite 4403B, Cleveland, OH, 44114
Phone
(216) 273-4000
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1448342

The full lists. Form D filings in Ohio: 1,071 rows, $53.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 4, 2017New notice$6,000,000$1,311,202$4,688,79846Sep 22, 2017sec.gov
May 19, 2015New notice$7,386,412$7,386,412$037May 4, 2015sec.gov
Nov 20, 2013New notice$5,000,000$5,000,000$045Oct 31, 2013sec.gov
Aug 8, 2012Amendment$22,060,000$22,060,000$035Sep 30, 2008sec.gov
Feb 3, 2012Amendment$20,000,000$12,000,000$8,000,00034Sep 30, 2008sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Matthew PollmanExecutive Officer, Director
Linda TuftsDirector
George AridaDirector
James BolandDirector
Suzette DutchDirector
Rahul ArasExecutive Officer, Director
Roger NewtonDirector
Jack MinerDirector

Other biotechnology companies in Ohio that filed recently

Every Form D from the week of Oct 2, 2017 · All recent filings in Ohio · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what JUVENTAS THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.